Recent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspective

References

• Achilli T-M, Meyer J, Morgan JR. 2012. Advances in the formation, use and understanding of multi-cellular spheroids. Expert Opin Biol Ther. 12:1347–1360.
   PubMed Web of Science ®Google Scholar
• Ahmed SW, Siddiqi ZA. 2006. Antiepileptic drugs and liver disease. Seizure. 15:156–164.
   PubMed Web of Science ®Google Scholar
• Alqahtani S, Mohamed LA, Kaddoumi A. 2013. Experimental models for predicting drug absorption and metabolism. Expert Opin Drug Metab Toxicol. 9:1241–1254.
   PubMed Web of Science ®Google Scholar
• Antonchuk J. 2013. Formation of embryoid bodies from human pluripotent stem cells using AggreWell plates. Methods Mol Biol. 946:523–533.
   PubMedGoogle Scholar
• Antoni D, Burckel H, Josset E, Noel G. 2015. Three-dimensional cell culture: a breakthrough in vivo. Int J Mol Sci. 16:5517–5527.
   PubMed Web of Science ®Google Scholar
• Aucamp J, Calitz C, Bronkhorst AJ, Wrzesinski K, Hamman JH, Gouws C, Pretorius PJ. 2017. Cell-free DNA in a three-dimensional spheroid cell culture model: a preliminary study. Int J Biochem Cell Biol. 89:182–192.
   PubMed Web of Science ®Google Scholar
• Baudoin R, Griscom L, Prot JM, Legallais C, Leclerc E. 2011. Behavior of HepG2/C3A cell cultures in a microfluidic bioreactor. Biochem Eng J. 53:172–181.
   Web of Science ®Google Scholar
• Baumans V. 2004. Use of animals in experimental research: an ethical dilemma? Gene Ther. 11:S64–S66.
   PubMed Web of Science ®Google Scholar
• Bell CC, Hendriks DFG, Moro SML, Ellis E, Walsh J, Renblom A, Puigvert LF, Dankers ACA, Jacobs F, Snoeys J, et al. 2016. Characterization of primary human hepatocytes spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep. 6:25187. [accessed 2017 Nov 22]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855186/pdf/srep25187.pdf
   PubMed Web of Science ®Google Scholar
• Benam KH, Dauth S, Hassell B, Herland A, Jain A, Jang K-J, Karalis K, Kim HJ, MacQueen L, Mahmoodian R, et al. 2015. Engineered in vitro disease models. Annu Rev Pathol. 10:195–262.
   PubMed Web of Science ®Google Scholar
• Bernal W, Auzinger G, Dhawan A, Wendon J. 2010. Acute liver failure. Lancet. 376:190–201.
   PubMed Web of Science ®Google Scholar
• Bhise NS, Manoharan V, Massa S, Tamayol A, Ghaderi M, Miscuglio M, Lang Q, Zhang YS, Shin SR, Calzone G, et al. 2016. A liver-on-a-chip platform with bioprinted hepatic spheroids. Biofabrication 8:014101. [accessed 2017 Nov 22]. http://iopscience.iop.org/article/10.1088/1758-5090/8/1/014101/pdf
   PubMed Web of Science ®Google Scholar
• Brajša K. 2016. Three-dimensional cell cultures as a new tool in drug discovery. Period Biol. 118:59–65.
   Web of Science ®Google Scholar
• Brandon EFA, Raap CD, Meijerman I, Beijnen JH, Schellens JHM. 2003. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol Appl Pharmacol. 189:233–246.
   PubMed Web of Science ®Google Scholar
• Breslin S, O’Driscoll L. 2013. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today. 18:240–249.
   PubMed Web of Science ®Google Scholar
• Breslin S, O'Driscoll L. 2016. The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance. Oncotarget. 7:45745–45756.
   PubMed Web of Science ®Google Scholar
• Davila JC, Xu JJ, Hoffmaster KA. 2007. Current in vitro models to study drug-induced liver injury. In: Sahu SC, editor. Hepatotoxicity: from genomics to in vitro and in vivo models. England: Wiley; p. 3–55.
   Google Scholar
• Diekmann H, Hill A. 2013. ADMETox in zebrafish. Drug Discov Today. 10:e31–e35.
   Google Scholar
• Donato MT, Lahoz A, Castell JV, Gómez-Lechón MJ. 2008. Cell lines: a tool for in vitro drug metabolism studies. Curr Drug Metab. 9:1–11.
   PubMed Web of Science ®Google Scholar
• Driessen M, Kienhuis AS, Pennings JLA, Pronk TE, van de Brandhof E-J, Roodbergen M, Spaink HP, van de Water B, van der Ven LTM. 2013. Exploring the zebrafish embryo as an alternative model for the evaluation of liver toxicity by histopathology and expression profiling. Arch Toxicol. 87:807–823.
   PubMed Web of Science ®Google Scholar
• Edmondson R, Broglie JJ, Adcock AF, Yang L. 2014. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. ASSAY Drug Dev Technol. 12:207–218.
   PubMed Web of Science ®Google Scholar
• Ekins S, Ring BJ, Grace J, McRobie-Belle DJ, Wrighton SA. 2000. Present and future in vitro approaches for drug metabolism. J Pharmacol Toxicol Methods. 44:313–324.
   PubMed Web of Science ®Google Scholar
• Fang Y, Eglen RM. 2017. Three-dimensional cell cultures in drug discovery and development. SLAS Discov. 22:456–472.
   PubMed Web of Science ®Google Scholar
• Featherstone B. 2007. Causes of liver disease and dysfunction. In: North-Lewis P, editor. Drugs and the liver. London: Pharmaceutical Press; p. 49–72.
   Google Scholar
• Fey SJ, Wrzesinski K. 2012a. Determination of drug toxicity using 3D Spheroids constructed from an immortal human hepatocyte cell line. Toxicol Sci. 127:403–411.
   PubMed Web of Science ®Google Scholar
• Fey SJ, Wrzesinski K. 2012b. Bioreactor with lid for easy access to incubation cavity. Patent No. WO2012/079577 A1.
   Google Scholar
• Fey SJ, Wrzesinski K. 2013. Determination of acute lethal and chronic lethal dose thresholds of valproic acid using 3D spheroids constructed from the immortal human hepatocyte cell line HepG2/C3A. In: Boucher A, editor. Valproic acid. New York: Nova Science Publishers, Inc; p. 141–165.
   Google Scholar
• Flemming A, Alderton WK. 2013. Zebrafish in pharmaceutical industry research: finding the best fit. Drug Discov Today. 10:e43–e50.
   Google Scholar
• Freires IA, Sardi JC, de Castro RD, Rosalen PL. 2017. Alternative animal and non-animal models for drug discovery and development: bonus or burden? Pharm Res. 34:681–686.
   PubMed Web of Science ®Google Scholar
• George J. 1995. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology. 21:120–128.
   PubMed Web of Science ®Google Scholar
• Giri S, Acikgöz A, Pathak P, Gutschker S, Kürsten A, Nieber K, Bader A. 2012. Three dimensional cultures of rat liver cells using a natural self-assembling nanoscaffold in a clinically relevant bioreactor for bioartificial liver construction. J Cell Physiol. 227:313–327.
   PubMed Web of Science ®Google Scholar
• Guillouzo A. 1998. Liver models in in vitro toxicology. Environ Health Perspect. 106:511–532.
   PubMed Web of Science ®Google Scholar
• Gunness P, Mueller D, Shevchenko V, Heinzle E, Ingelman-Sundberg M, Noor F. 2013. 3D Organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies. Toxicol Sci. 133:67–78.
   PubMed Web of Science ®Google Scholar
• Guo WM, Loh XJ, Tan EY, Loo JSC, Ho VHB. 2014. Development of a magnetic 3D spheroid platform with potential application for high-throughput drug screening. Mol Pharm. 11:2182–2189.
   PubMed Web of Science ®Google Scholar
• Gupta N, Liu JR, Patel B, Solomon DE, Vaidya B, Gupta V. 2016. Microfluidics-based 3D cell culture models: utility in novel drug discovery and delivery research. Bioeng Trans Med. 1:63–68.
   PubMed Web of Science ®Google Scholar
• Hayward AS, Eissa AM, Maltman DJ, Sano N, Przyborski SA, Cameron NR. 2013. Galactose-functionalized PolyHIPE scaffolds for use in routine three dimensional culture of mammalian hepatocytes. Biomacromolecules. 14:4271–4277.
   PubMed Web of Science ®Google Scholar
• He J-H, Guo S-Y, Zhu F, Zhu J-J, Chen Y-X, Huang C-J, Gao J-M, Dong Q-X, Xuan Y-X, Li C-Q. 2013. A zebrafish phenotypic assay for assessing drug-induced hepatotoxicity. J Pharmacol Toxicol Methods. 67:25–32.
   PubMed Web of Science ®Google Scholar
• Heffernan JM, Overstreet DJ, Le LD, Vernon BL, Sirianni RW. 2015. Bioengineered scaffolds for 3D analysis of glioblastoma proliferation and invasion. Ann Biomed Eng. 43:1965–1977.
   PubMed Web of Science ®Google Scholar
• Heidelbaugh JJ, Bruderly M. 2006. Cirrhosis and chronic liver failure: part I diagnosis and evaluation. Am Fam Phys. 74:756–762.
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Gómez Lechón MJ, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna JG, Gustavsson L, Lohmann C, Skonberg C, et al. 2007. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxic studies. Drug Metab Rev. 39:159–134.
   PubMed Web of Science ®Google Scholar
• Hill AJ, Teraoka H, Heideman W, Peterson RE. 2005. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci. 86:6–19.
   PubMed Web of Science ®Google Scholar
• Hirschfield GM, Heathcote EJ, Gershwin ME. 2010. Reviews in basic and clinical gastroenterology and hepatology. Gastroenterology. 139:1481–1496.
   PubMed Web of Science ®Google Scholar
• Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA. 2010. Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol. 148:3–15.
   PubMed Web of Science ®Google Scholar
• Hoffman AS. 2012. Hydrogels for biomedical applications. Adv Drug Deliv Rev. 64:18–23.
   Web of Science ®Google Scholar
• Holt A, Smith A. 2007. An introduction to the anatomy of the liver. In: North-Lewis P, editor. Drugs and the liver. London: Pharmaceutical Press; p. 3–21.
   Google Scholar
• Hughes CS, Postovit LM, Lajoie GA. 2010. Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics. 10:1886–1890.
   PubMed Web of Science ®Google Scholar
• Huh D, Hamilton GA, Ingber DE. 2011. From 3D cell culture to organs-on-chips. Trends Cell Biol. 21:745–754.
   PubMed Web of Science ®Google Scholar
• Ivanov DP, Parker TL, Walker DA, Alexander C, Ashford MB, Gellert PR, Garnett MC. 2014. Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres. PLoS One. 9:e103817. [accessed 2017 Nov 22]. https://doi.org/10.1371/journal.pone.0103817
   PubMed Web of Science ®Google Scholar
• Janorkar AV, Harris LM, Murphey BS, Sowell BL. 2011. Use of three-dimensional spheroids of hepatocyte-derived reporter cells to study the effects of intracellular fat accumulation and subsequent cytokine exposure. Biotechnol Bioeng. 108:1171–1181.
   PubMed Web of Science ®Google Scholar
• Jiang H-L, Kim Y-K, Cho K-H, Jang Y-C, Choi Y-J, Chung J-H, Cho C-S. 2010. Roles of spheroid formation of hepatocytes in liver tissue engineering. Int J Stem Cells. 3:69–73.
   PubMedGoogle Scholar
• Justice BA, Badr NA, Felder RA. 2009. 3D cell culture opens new dimensions in cell-based assays. Drug Discov Today. 14:102–107.
   PubMed Web of Science ®Google Scholar
• Kang YB, Rawat S, Cirillo J, Bouchard M, Noh H. 2013. Layered long-term co-culture of hepatocytes and endothelial cells on a transwell membrane: toward engineering the liver sinusoid. Biofabrication. 5:045008. [accessed 2018 Jan 1]. https://doi.org/10.1088/1758-5082/5/4/045008
   PubMed Web of Science ®Google Scholar
• Kanuri G, Bergheim I. 2013. In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). IJMS. 14:11963–11980.
   Google Scholar
• Khoruzhenko AI. 2011. 2D- and 3D-cell culture. Biopolym Cell. 27:17–24.
   Google Scholar
• Kim J-Y, Fluri DA, Marchon R, Boonen K, Moharity S, Singh P, Hammad S, Landuyt B, Hengstler JG, Kelm JM, et al. 2015. 3D spherical microtissues and microfluidic technology for multi-tissue experiments and analysis. J Biotechnol. 205:24–35.
   PubMed Web of Science ®Google Scholar
• Kostrzewski T, Cornforth T, Snow SA, Ouro-Gnao L, Rowe C, Large EM, Hughes DJ. 2017. Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease. WJG. 23:204–215.
   PubMed Web of Science ®Google Scholar
• Lan S-F, Safiejko-Mroczka B, Starly B. 2010. Long-term cultivation of HepG2 liver cells encapsulated in alginate hydrogels: a study of cell viability, morphology and drug metabolism. Toxicol in vitro. 24:1314–1323.
   PubMed Web of Science ®Google Scholar
• Leite SB, Wilk-Zasadna I, Zaldivar JM, Airola E, Reis-Fernandes MA, Mennecozzi M, Guguen-Guillouzo C, Chesne C, Guillou C, Alves PM. 2012. Three-dimensional HepaRG model as an alternative tool for toxicity testing. Toxicol Sci. 130:106–116.
   PubMed Web of Science ®Google Scholar
• Liddle C, Stedman CAM. 2006. Hepatic metabolism of drugs CYP450 family: Major drug transporters and nuclear receptor regulation. Clin Gastroenterol Hepatol. 2:9241–9249.
   Google Scholar
• Lin R-Z, Chang HY. 2008. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J. 3:1172–1184.
   PubMedGoogle Scholar
• Lipscomb JC, Poet TS. 2008. In vitro measurements of metabolism for application in pharmacokinetic modelling. Pharmacol Ther. 118:82–103.
   PubMed Web of Science ®Google Scholar
• Liu Y, Meyer C, Xu C, Weng H, Hellerbrand C, ten Dijke P, Dooley S. 2013. Animal models of chronic liver disease. Am J Physiol Gastrointest Liver Physiol. 304:G449–G468.
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis GMM, De Kanter R. 2006. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol. 2:875–894.
   PubMed Web of Science ®Google Scholar
• Maschmeyer I, Lorenz AK, Schimek K, Hasenberg T, Ramme AP, Hübner J, Lindner M, Drewell C, Bauer S, Thomas A, et al. 2015. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip. 15:2688–2699.
   PubMed Web of Science ®Google Scholar
• Materne E-M, Ramme AP, Terrasso AP, Serra M, Alves PM, Brito C, Sakharov DA, Tonevitsky AG, Lauster R, Marx U, et al. 2015. A multi-organ chip co-culture of neurospheres and liver equivalents for long-term substance testing. J Biotechnol. 205:36–46.
   PubMed Web of Science ®Google Scholar
• McGrath P, Li C-Q. 2008. Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today. 13:394–401.
   PubMed Web of Science ®Google Scholar
• Merrel MD, Cherrington NJ. 2011. Drug metabolism alterations in nonalcoholic fatty liver disease. Drug Metab Rev. 43:317–334.
   PubMed Web of Science ®Google Scholar
• Mesens N, Crawford AD, Menke A, Hung PD, Van Goethem F, Nuyts R, Hansen E, Wolterbeek A, Van Gompel J, De Witte P, et al. 2015. Are zebrafish larvae suitable for assessing the hepatotoxicity potential of drug candidates? J Appl Toxicol. 35:1017–1029.
   PubMed Web of Science ®Google Scholar
• Messner S, Agarkova I, Moritz W, Kelm JM. 2013. Multi-cell type human liver microtissues for hepatotoxicity testing. Arch Toxicol. 87:209–213.
   PubMed Web of Science ®Google Scholar
• Miranda JP, Rodrigues A, Tostões RM, Leite S, Zimmerman H, Carrondo MJT, Alves PM. 2010. Extending hepatocyte functionality for drug-testing applications using high-viscosity alginate-encapsulated three-dimensional cultures in bioreactors. Tissue Eng Methods. 16:1223–1232.
   PubMed Web of Science ®Google Scholar
• Murphy SV, Atala A. 2014. 3D bioprinting of tissues and organs. Nat Biotechnol. 32:773–785.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Kato N, Aizawa K, Mizutani R, Yamauchi J, Tanoue A. 2011. Expression of albumin and cytochrome P450 enzymes in HepG2 cells cultured with a nanotechnology-based culture plate with microfabricated scaffold. J Toxicol Sci. 36:625–633.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Mizutani R, Sanbe A, Enosawa S, Kasahara M, Nakagawa A, Ejiri Y, Murayama N, Miyamoto Y, Torii T, et al. 2011. Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system. J Biosci Bioeng. 111:78–84.
   PubMed Web of Science ®Google Scholar
• Nelson LJ, Morgan K, Treskes P, Samuel K, Henderson CJ, LeBled C, Homer N, Grant MH, Hayes PC, Plevris JN, et al. 2017. Human hepatic HepaRG cells maintain an organotypic Phenotype with high intrinsic CYP450 activity/metabolism and significantly outperform standard HepG2/C3A cells for pharmaceutical and therapeutic applications. Basic Clin Pharmacol Toxicol. 120:30–37.
   PubMed Web of Science ®Google Scholar
• Ohkura T, Ohta K, Nagao T, Kusumoto K, Koeda A, Ueda T, Jomura T, Ikeya T, Ozeki E, Wada K, et al. 2014. Evaluation of human hepatocytes cultured by three-dimensional spheroid systems for drug metabolism. Drug Metab Pharmacokinet. 29:373–378.
   PubMed Web of Science ®Google Scholar
• Page H, Flood P, Reynaud EG. 2013. Three-dimensional tissue cultures: current trends and beyond. Cell Tissue Res. 352:123–131.
   PubMed Web of Science ®Google Scholar
• Paixåo RL, Schramm FR. 1999. Ethics and animal experimentation: what is debated? Cad Saúde Pública. 15:99–110.
   PubMedGoogle Scholar
• Panqueva RPL. 2014. Approaches to pathological diagnosis of cholestatic diseases. The Revista Colombiana De Gastroenterología. 29:183–192.
   Google Scholar
• Privitera G, Agarwal B, Jalan R. 2014. Acute liver failure: pathophysiology basic, and the current and emerging therapies. Emergency Med J. 1:99–107.
   Google Scholar
• Prot JM, Bunescu A, Elena-Herrmann B, Aninat C, Snouber LC, Griscom L, Razan F, Bois FY, Legallais C, Brochot C, et al. 2012. Predictive toxicology using systemic biology and liver microfluidic “on chip” approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 259:270–280.
   PubMed Web of Science ®Google Scholar
• Raghavan S, Mehta P, Horst EN, Ward MR, Rowley KR, Mehta G. 2016. Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity. Oncotarget. 7:16948–16961.
   PubMed Web of Science ®Google Scholar
• Rahman TM, Hodgson HJF. 2000. Animal models of acute hepatic failure. Int J Clin Exp Pathol. 81:145–157.
   Google Scholar
• Ramadori G, Moriconi F, Malik I, Dudas J. 2008. Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol Pharmacol. 591:107–117.
   Google Scholar
• Ranga A, Gjorevski N, Lutolf MP. 2014. Drug discovery through stem cell-based organoid models. Adv Drug Deliv Rev. 69–70:19–28.
   PubMed Web of Science ®Google Scholar
• Ravi M, Paramesh V, Kaviya SR, Anuradha E, Solomon FDP. 2015. 3D cell culture systems: advantages and applications. J Cell Physiol. 230:16–26.
   PubMed Web of Science ®Google Scholar
• Redfern WS, Waldron G, Winter MJ, Butler P, Holbrook M, Wallis R, Valentin J-P. 2008. Zebrafish assays as early safety pharmacology screens: paradigm shift or red herring? J Pharmacol Toxicol Methods. 58:110–117.
   PubMedGoogle Scholar
• Rookmaaker MB, Schutgens F, Verhaar MC, Clevers H. 2015. Development and application of human adult stem or progenitor cell organoids. Nat Rev Nephrol. 11:546–554.
   PubMed Web of Science ®Google Scholar
• Sabolić I, Breljak D, Ljubojević M, Brzica H. 2011. Are mice, rats, and rabbits good models for physiological, pharmacological and toxicological studies in humans? Periodicum Biologorum. 133:7–16.
   Google Scholar
• Schutte M, Fox B, Baradez M-O, Devonshire A, Minguez J, Bokhari M, Przyborski S, Marshall D. 2011. Rat primary hepatocytes show enhanced performance and sensitivity to acetaminophen during three-dimensional culture on a polystyrene scaffold designed for routine use. ASSAY Drug Dev Technol. 9:475–486.
   PubMed Web of Science ®Google Scholar
• Shearier E, Xing Q, Qian Z, Zhao F. 2016. Physiologically low oxygen enhances biomolecule production and stemness of Mesenchymal stem cell spheroids. Tissue Eng Part C Methods. 22:360–369.
   PubMed Web of Science ®Google Scholar
• Shen C, Zhang G, Meng Q. 2010. Enhancement of the predicted drug hepatotoxicity in gel entrapped hepatocytes within polysulfone-g-poly (ethylene glycol) modified hollow fiber. Toxicol Appl Pharmacol. 249:140–147.
   PubMed Web of Science ®Google Scholar
• Singh A, Bhat TK, Sharma OP. 2011. Clinical biochemistry of hepatotoxicity. J Clin Toxicol. S4:S4-001. [accessed 2017 Nov 22]. https://www.omicsonline.org/clinical-biochemistry-of-hepatotoxicity-2161-0495.S4-001.pdf
   PubMedGoogle Scholar
• Sirenko O, Hancock MK, Hesley J, Hong D, Cohen A, Gentry J, Carlson CB, Mann DA. 2016. Phenotypic characterization of toxic compound effects on liver spheroids derived from iPSC using confocal imaging and three-dimensional image analysis. ASSAY Drug Dev Technol. 14:281–394.
   Web of Science ®Google Scholar
• Soldatow VY, Lecluyse EL, Griffith LG, Rusyn I. 2013. In vitro models for liver toxicity testing. Toxicol Res. 2:23–39.
   PubMed Web of Science ®Google Scholar
• Szabo M, Veres Z, Baranyai Z, Jakab F, Jemnitz K, Deli MA. 2013. Comparison of human hepatoma HepaRG cells with human and rat hepatocytes in uptake transport assays in order to predict a risk of drug induced hepatotoxicity. PloS One. 8:e59432–e59422. [accessed 2017 Nov 22]. http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0059432&type=printable
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Hori Y, Yamamoto T, Urashima T, Ohara Y, Tanaka H. 2015. Three-dimensional (3D) spheroid cultures improve the metabolic gene expression profiles of HepaRG cells. Biosci Rep. 35:e00208. [accessed 2017 Nov 22]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613666/pdf/bsr035e208.pdf
   Web of Science ®Google Scholar
• Tingle MD, Helsby NA. 2006. Can in vitro drug metabolism studies with human tissue replace in vivo animal models? Environ Toxicol Pharmacol. 21:184–190.
   PubMed Web of Science ®Google Scholar
• Torok E, Lutgehetmann M, Bierwolf J, Melbeck S, Düllmann J, Nashan B, Ma PX, Pollok JM. 2011. Primary human hepatocytes on biodegradable poly(l-lactic acid) matrices: a promising model for improving transplantation efficiency with tissue engineering. Liver Transpl. 17:104–114.
   PubMed Web of Science ®Google Scholar
• Tung Y-C, Hsiao AY, Allen SG, Torisawa YS, Ho M, Takayama S. 2010. High-throughput spheroid culture drug testing in 384 hanging drop array. Analyst. 136:417–620.
   Web of Science ®Google Scholar
• Van Zijl F, Mikulits W. 2010. Hepatospheres: Three-dimensional cell cultures resemble physiological conditions of the liver. WJH. 2:1–7.
   PubMedGoogle Scholar
• Vekemans K, Braet F. 2005. Structural and functional aspects of the liver and liver sinusoidal cells in relation to colon carcinoma metastasis. WJG. 11:5095–5102.
   PubMed Web of Science ®Google Scholar
• Vercauteren K, De Jong Y, Meuleman P. 2014. HCV animal models and liver disease. J Hepatol. 61:S26–S33.
   PubMed Web of Science ®Google Scholar
• Verhulsel M, Vignes M, Descroix S, Malaquin L, Vignjevic DM, Viovy J-L. 2014. A review of microfabrication and hydrogel engineering for micro-organs on chips. Biomaterials. 35:1816–1832.
   PubMed Web of Science ®Google Scholar
• Wilkinson GR. 2005. Drug metabolism and variability among patients in drug response. N Engl J Med. 352:2211–2221.
   PubMed Web of Science ®Google Scholar
• Wolf PL. 1999. Biochemical diagnosis of liver disease. Indian J Clin Biochem. 14:59–90.
   PubMedGoogle Scholar
• Wong SF, No DY, Choi YY, Kim DS, Chung BG, Lee S-H. 2011. Concave microwell based size-controllable hepatosphere as a three-dimensional liver tissue model. Biomaterials. 32:8087–8096.
   PubMed Web of Science ®Google Scholar
• Wrzesinski K, Fey SJ. 2013. After trypsinisation, 3D spheroids of C3A hepatocytes need 18 days to re-establish similar levels of key physiological functions to those seen in the liver. Toxicol Res. 2:123–135.
   Web of Science ®Google Scholar
• Wrzesinski K, Fey SJ. 2015. From 2D to 3D – a new dimension for modelling the effect of natural products on human tissue. CPD. 21:5605–5616.
   Google Scholar
• Wrzesinski K, Magnone MC, Hansen LV, Kruse ME, Bergauer T, Bobadilla M, Gubler M, Mizrahi J, Zhang K, Andreasen CM, et al. 2013. HepG2/C3A 3D spheroids exhibit stable physiological functionality for at least 24 days after recovering from trypsinisation. Toxicol Res. 2:163–172.
   Web of Science ®Google Scholar
• Wrzesinski K, Rogowska-Wrzesinska A, Kanlaya R, Borkowski K, Schwämmle V, Dai J, Joensen KE, Wojdyla K, Carvalho VB, Fey SJ. 2014. The cultural divide: exponential growth in classical 2D and metabolic equilibrium in 3D environments. PloS One. 9:e106973. [accessed 2017 Nov 22]. https://doi.org/10.1371/journal.pone.0106973
   Google Scholar
• Yip D, Cho CH. 2013. A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing. Biochem Biophys Res Commun. 433:327–332.
   PubMed Web of Science ®Google Scholar
• Zanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R, Bevilacqua A, Tesei A. 2016. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci Rep. 6:19103. [accessed 2017 Nov 22]. https://www.nature.com/articles/srep19103.pdf
   Web of Science ®Google Scholar
• Zarowna-Dabrowska A, McKenna EO, Schutte ME, Glidle A, Chen L, Cuestas-Ayllon C, Marshall D, Pitt A, Dawson MD, Gu E, et al. 2012. Generation of primary hepatocyte microarrays by piezoelectric printing. Colloids Surf B Biointerfaces. 89:126–132.
   PubMed Web of Science ®Google Scholar
• Zhang D, Luo G, Ding X, Lu C. 2012. Preclinical experimental models of drug metabolism and disposition in drug discovery and development. Acta Pharma Sin B. 2:549–561.
   Google Scholar
• Zhang RR, Takebe T, Miyazaki L, Takayama M, Koike H, Kimura M, Enomura M, Zheng YW, Sekine K, Taniguchi H. 2014. Efficient hepatic differentiation of human induced pluripotent stem cells in a three-dimensional microscale culture. Methods Mol Biol. 1210:131–134.
   PubMedGoogle Scholar